000 01450 a2200457 4500
005 20250512195327.0
264 0 _c19811025
008 198110s 0 0 eng d
022 _a0017-5749
024 7 _a10.1136/gut.22.7.549
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLong, R G
245 0 0 _aSomatostatin, gastrointestinal peptides, and the carcinoid syndrome.
_h[electronic resource]
260 _bGut
_cJul 1981
300 _a549-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBlood Glucose
_xanalysis
650 0 4 _aErythema
_xetiology
650 0 4 _aEthanol
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGastrointestinal Hormones
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMalignant Carcinoid Syndrome
_xcomplications
650 0 4 _aMiddle Aged
650 0 4 _aNeurotensin
_xblood
650 0 4 _aNorepinephrine
_xpharmacology
650 0 4 _aPancreatic Hormones
_xblood
650 0 4 _aPentagastrin
_xpharmacology
650 0 4 _aPeptide Fragments
_xtherapeutic use
650 0 4 _aSomatostatin
_xpharmacology
700 1 _aPeters, J R
700 1 _aBloom, S R
700 1 _aBrown, M R
700 1 _aVale, W
700 1 _aRivier, J E
700 1 _aGrahame-Smith, D G
773 0 _tGut
_gvol. 22
_gno. 7
_gp. 549-53
856 4 0 _uhttps://doi.org/10.1136/gut.22.7.549
_zAvailable from publisher's website
999 _c6114993
_d6114993